63260-82-2
63260-82-2结构式
- 常用中文名：1-苄基-4-苯基氨基-4-哌啶羧酸乙酯
- 常用英文名：ethyl 1-benzyl-4-(phenylamino)piperidine-4-carboxylate
- CAS号：63260-82-2
- 分子式：C21H26N2O2
- 分子量：338.44300
- 发布时间：2018-12-04 10:36:19
- 更新时间：2024-01-10 15:21:40
| 中文名 | 1-苄基-4-苯基氨基-4-哌啶羧酸乙酯 |
|---|---|
| 英文名 | ethyl 4-anilino-1-benzylpiperidine-4-carboxylate |
| 英文别名 |
Ethyl 1-benzyl-4-(phenylamino)piperidine-4-carboxylate
4-anilino-1-benzyl-4-carboethoxy-piperidine ethyl 4-anilino-1-benzylisonipecotate 4-Anilino-1-benzylpiperidin-4-carbonsaeure-ethylester N-Benzyl-4-carbethoxy-4-anilinopiperidine 4-anilino-1-benzyl-piperidine-4-carboxylic acid ethyl ester ethyl 1-benzyl-4-phenylamino-4-piperidinecarboxylate EINECS 264-054-9 |
| 密度 | 1.153g/cm3 |
|---|---|
| 沸点 | 462.7ºC at 760 mmHg |
| 分子式 | C21H26N2O2 |
| 分子量 | 338.44300 |
| 闪点 | 233.6ºC |
| 精确质量 | 338.19900 |
| PSA | 41.57000 |
| LogP | 3.70730 |
| 折射率 | 1.601 |
| 海关编码 | 2933399090 |
|---|
|
~%
63260-82-2 |
| 文献：VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2006/105035 A2, 2006 ; Location in patent: Page/Page column 56-57 ; WO 2006/105035 A2 |
|
~77%
63260-82-2 |
| 文献：Colapret; Diamantidis; Spencer; Spaulding; Rudo Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 968 - 974 |
|
~%
63260-82-2 |
| 文献：Kiessling, Anthony J.; McClure, Cynthia K. Synthetic Communications, 1997 , vol. 27, # 5 p. 923 - 937 |
|
~%
63260-82-2 |
| 文献：Colapret; Diamantidis; Spencer; Spaulding; Rudo Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 968 - 974 |
|
~%
63260-82-2 |
| 文献：Colapret; Diamantidis; Spencer; Spaulding; Rudo Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 968 - 974 |
|
~%
63260-82-2 |
| 文献：Colapret; Diamantidis; Spencer; Spaulding; Rudo Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 968 - 974 |
|
~%
63260-82-2 |
| 文献：Parys, Marc Van; Vandewalle, Maurits Bulletin des Societes Chimiques Belges, 1981 , vol. 90, # 7 p. 749 - 756 |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |